Is higher resting heart rate associated with increased mortality and cardiovascular events in patients with moderate CKD?
Higher resting heart rate is associated with increased mortality and cardiovascular events in moderate CKD, suggesting a potential target for future interventional studies.
Resting heart rate is associated with metabolic syndrome in moderate CKD. Higher resting heart is associated with increased mortality and possibly cardiovascular events in this population. Interventional studies to examine whether a target resting heart rate of 60-74/min improves cardiovascular outcomes and survival in moderate CKD are warranted.
Beddhu et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: